<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">Hematologic malignancies</z:e> are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of conditions with an unclear etiology </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 is associated with increased risk of developing <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:mp ids='MP_0009440'>myeloma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>A literature search identified 26 studies (13 case-control and 13 cohort studies) evaluating such an association </plain></SENT>
<SENT sid="3" pm="."><plain>Outcome was calculated as the odds ratio (OR) using a random effects model </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneity</z:hpo> and publication bias were evaluated using the I(2) index and the trim-and-fill analysis, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Quality was assessed using the Newcastle-Ottawa scale </plain></SENT>
<SENT sid="6" pm="."><plain>The OR for non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was increased at 1.22 (95% confidence interval [CI], 1.07-1.39; P &lt; .01) but the OR for Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was not </plain></SENT>
<SENT sid="7" pm="."><plain>There was an increased OR for peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR = 2.42, 95% CI, 1.24-4.72; P = .009) but not for other non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes </plain></SENT>
<SENT sid="8" pm="."><plain>The OR for <z:hpo ids='HP_0001909'>leukemia</z:hpo> was 1.22 (95% CI, 1.03-1.44; P = .02) and the OR for <z:mp ids='MP_0009440'>myeloma</z:mp> was 1.22 (95% CI, 0.98-1.53; P = .08) </plain></SENT>
<SENT sid="9" pm="."><plain>Although <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 seems to increase the risk of developing <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:mp ids='MP_0009440'>myeloma</z:mp>, future studies should focus on evaluating other potential confounders such as <z:hpo ids='HP_0001513'>obesity</z:hpo>, dietary habits, physical activity, and/or <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> therapy </plain></SENT>
</text></document>